"Gene Dosage" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The number of copies of a given gene present in the cell of an organism. An increase in gene dosage (by GENE DUPLICATION for example) can result in higher levels of gene product formation. GENE DOSAGE COMPENSATION mechanisms result in adjustments to the level GENE EXPRESSION when there are changes or differences in gene dosage.
Descriptor ID |
D018628
|
MeSH Number(s) |
G05.380.350
|
Concept/Terms |
Gene Dosage- Gene Dosage
- Dosage, Gene
- Dosages, Gene
- Gene Dosages
- Gene Copy Number
- Copy Number, Gene
- Copy Numbers, Gene
- Gene Copy Numbers
- Number, Gene Copy
- Numbers, Gene Copy
|
Below are MeSH descriptors whose meaning is more general than "Gene Dosage".
Below are MeSH descriptors whose meaning is more specific than "Gene Dosage".
This graph shows the total number of publications written about "Gene Dosage" by people in this website by year, and whether "Gene Dosage" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1997 | 0 | 2 | 2 |
2000 | 0 | 1 | 1 |
2001 | 2 | 0 | 2 |
2003 | 0 | 2 | 2 |
2004 | 0 | 1 | 1 |
2005 | 1 | 1 | 2 |
2006 | 0 | 4 | 4 |
2007 | 1 | 0 | 1 |
2008 | 0 | 2 | 2 |
2009 | 0 | 1 | 1 |
2010 | 0 | 3 | 3 |
2011 | 1 | 0 | 1 |
2012 | 0 | 2 | 2 |
2013 | 1 | 3 | 4 |
2015 | 0 | 1 | 1 |
2016 | 0 | 5 | 5 |
2017 | 1 | 0 | 1 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gene Dosage" by people in Profiles.
-
Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line. Sci Rep. 2021 03 11; 11(1):5690.
-
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma. J Clin Invest. 2017 Mar 01; 127(3):830-842.
-
PERK Is a Haploinsufficient Tumor Suppressor: Gene Dose Determines Tumor-Suppressive Versus Tumor Promoting Properties of PERK in Melanoma. PLoS Genet. 2016 Dec; 12(12):e1006518.
-
Disrupted mitochondrial genes and inflammation following stroke. Life Sci. 2016 Dec 01; 166:139-148.
-
Dissection of the Major Hematopoietic Quantitative Trait Locus in Chromosome 6q23.3 Identifies miR-3662 as a Player in Hematopoiesis and Acute Myeloid Leukemia. Cancer Discov. 2016 09; 6(9):1036-51.
-
X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sj?gren's Syndrome. Arthritis Rheumatol. 2016 05; 68(5):1290-1300.
-
Genetic and Developmental Basis of Cardiovascular Malformations. Clin Perinatol. 2016 Mar; 43(1):39-53.
-
A multicenter, cross-platform clinical validation study of cancer cytogenomic arrays. Cancer Genet. 2015 Nov; 208(11):525-36.
-
Hyperactive transforming growth factor-?1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model. J Bone Miner Res. 2013 Dec; 28(12):2476-89.
-
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class. Clin Cancer Res. 2013 Sep 15; 19(18):4951-60.